International Biotechnology (LON:IBT) Issues Earnings Results

International Biotechnology (LON:IBT) posted its earnings results on Tuesday. The company reported GBX (4.83) earnings per share for the quarter, Digital Look Earnings reports. The business had revenue of GBX 24 million during the quarter. International Biotechnology had a negative net margin of 6.26% and a negative return on equity of 0.45%.

International Biotechnology Stock Up 1.7%

LON IBT opened at GBX 1,007.22 on Thursday. The stock has a market cap of £320.58 million, a P/E ratio of -306.14 and a beta of 0.49. The company’s 50-day simple moving average is GBX 933.79 and its 200 day simple moving average is GBX 930.48. International Biotechnology has a twelve month low of GBX 546 and a twelve month high of GBX 1,010.

About International Biotechnology

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.